BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20826041)

  • 1. [Granulomatous hepatitis due to Mycobacterium complex following Bacillus Calmette-Guérin intravesical instillation].
    Villamil-Cajoto I; Jove MJ; Serrano M; Pousa M
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):759-61; author reply 761-2.. PubMed ID: 20826041
    [No Abstract]   [Full Text] [Related]  

  • 2. [Granulomatous hepatitis and sepsis secondary to intravesical instillation of bacillus Calmette-Guérin].
    Garmilla-Ezquerra P; Martínez-De Las Cuevas G; Hernández-Hernández JL
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):656-7. PubMed ID: 22683174
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG-related granulomatous hepatitis.
    Hristea A; Neacsu A; Ion DA; Streinu-Cercel A; Stăniceanu F
    Pneumologia; 2007; 56(1):32-4. PubMed ID: 17491206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy].
    Goulabchand R; Dufour S; Murez T; Broner J; Rivière S; Guilpain P; Le Quellec A
    Med Mal Infect; 2017 Dec; 47(8):558-561. PubMed ID: 28943176
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
    Leebeek FW; Ouwendijk RJ; Kolk AH; Dees A; Meek JC; Nienhuis JE; Dingemans-Dumas AM
    Gut; 1996 Apr; 38(4):616-8. PubMed ID: 8707098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary tuberculosis caused by Mycobacterium bovis BCG variety, following intravesical instillation].
    Cameo MI; Lezcano MA; Gil D; Blas M
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):134-5. PubMed ID: 19695743
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
    Soylu A; Ince AT; Polat H; Yasar N; Ciltas A; Ozkara S; Tasci AI
    Ann Clin Microbiol Antimicrob; 2009 Apr; 8():12. PubMed ID: 19368735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration.
    Graziano DA; Jacobs D; Lozano RG; Buck RL
    J Urol; 1991 Oct; 146(4):1118-9. PubMed ID: 1895437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
    Marans HY; Bekirov HM
    J Urol; 1987 Jan; 137(1):111-2. PubMed ID: 3795348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
    Ersoy O; Aran R; Aydinli M; Yonem O; Harmanci O; Akdogan B; Pinar A; Sokmensuer C; Bayraktar Y
    Indian J Gastroenterol; 2006; 25(5):258-9. PubMed ID: 17090848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
    Harding GE; Lawlor DK
    J Vasc Surg; 2007 Jul; 46(1):131-4. PubMed ID: 17606130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.
    Deresiewicz RL; Stone RM; Aster JC
    J Urol; 1990 Dec; 144(6):1331-3; discussion 1333-4. PubMed ID: 2231918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.
    Ozbakkaloglu B; Tünger O; Sürücüoglu S; Lekili M; Kandiloglu AR
    Int Urol Nephrol; 1999; 31(1):49-53. PubMed ID: 10408303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
    Linn R; Klimberg IW; Wajsman Z
    J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal complications of intravesical bacillus Calmette-Guérin therapy.
    Modesto A; Marty L; Suc JM; Kleinknecht D; de Frémont JF; Marsepoil T; Veyssier P
    Am J Nephrol; 1991; 11(6):501-4. PubMed ID: 1819218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary disease following intravesical BCG treatment.
    Kesten S; Title L; Mullen B; Grossman R
    Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report.
    Hakim S; Heaney JA; Heinz T; Zwolak RW
    J Urol; 1993 Jul; 150(1):188-9. PubMed ID: 8510250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.